1. Home
  2. RR vs JBIO Comparison

RR vs JBIO Comparison

Compare RR & JBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RR
  • JBIO
  • Stock Information
  • Founded
  • RR 2016
  • JBIO 2024
  • Country
  • RR United States
  • JBIO United States
  • Employees
  • RR N/A
  • JBIO N/A
  • Industry
  • RR
  • JBIO
  • Sector
  • RR
  • JBIO
  • Exchange
  • RR Nasdaq
  • JBIO NYSE
  • Market Cap
  • RR 270.9M
  • JBIO 290.1M
  • IPO Year
  • RR 2023
  • JBIO N/A
  • Fundamental
  • Price
  • RR $2.01
  • JBIO $8.28
  • Analyst Decision
  • RR Strong Buy
  • JBIO Strong Buy
  • Analyst Count
  • RR 1
  • JBIO 2
  • Target Price
  • RR $3.50
  • JBIO $15.50
  • AVG Volume (30 Days)
  • RR 9.7M
  • JBIO 400.3K
  • Earning Date
  • RR 08-13-2025
  • JBIO 08-05-2025
  • Dividend Yield
  • RR N/A
  • JBIO N/A
  • EPS Growth
  • RR N/A
  • JBIO N/A
  • EPS
  • RR N/A
  • JBIO N/A
  • Revenue
  • RR $4,392,000.00
  • JBIO N/A
  • Revenue This Year
  • RR $36.86
  • JBIO N/A
  • Revenue Next Year
  • RR $113.58
  • JBIO N/A
  • P/E Ratio
  • RR N/A
  • JBIO N/A
  • Revenue Growth
  • RR N/A
  • JBIO N/A
  • 52 Week Low
  • RR $0.30
  • JBIO $1.61
  • 52 Week High
  • RR $5.20
  • JBIO $13.50
  • Technical
  • Relative Strength Index (RSI)
  • RR 50.59
  • JBIO N/A
  • Support Level
  • RR $1.91
  • JBIO N/A
  • Resistance Level
  • RR $2.33
  • JBIO N/A
  • Average True Range (ATR)
  • RR 0.12
  • JBIO 0.00
  • MACD
  • RR 0.03
  • JBIO 0.00
  • Stochastic Oscillator
  • RR 46.67
  • JBIO 0.00

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.

About JBIO JADE BIOSCIENCES INC

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

Share on Social Networks: